12 Health Care Stocks Moving In Friday's After-Market Session
Benzinga·10/10/2025 21:06:24
Listen to the news
Gainers
- Aclarion (NASDAQ:ACON) stock moved upwards by 28.8% to $11.08 during Friday's after-market session. The market value of their outstanding shares is at $4.9 million.
- Spyre Therapeutics (NASDAQ:SYRE) stock rose 13.2% to $21.64. The company's market cap stands at $1.2 billion.
- Inventiva (NASDAQ:IVA) stock moved upwards by 7.47% to $4.89. The company's market cap stands at $769.1 million.
- Immatics (NASDAQ:IMTX) stock increased by 6.17% to $11.0. The market value of their outstanding shares is at $1.3 billion.
- Nanobiotix (NASDAQ:NBTX) shares moved upwards by 5.93% to $25.0. The company's market cap stands at $1.4 billion.
- Gelteq (NASDAQ:GELS) stock increased by 5.38% to $1.37. The market value of their outstanding shares is at $13.6 million.
Losers
- Quoin Pharmaceuticals (NASDAQ:QNRX) stock declined by 21.7% to $16.06 during Friday's after-market session. The market value of their outstanding shares is at $4.7 million.
- CARISMA Therapeutics (NASDAQ:CARM) shares decreased by 14.17% to $0.13. The market value of their outstanding shares is at $11.4 million.
- Hyperion DeFi (NASDAQ:HYPD) stock fell 10.34% to $7.2. The market value of their outstanding shares is at $82.8 million.
- cbdMD (AMEX:YCBD) shares decreased by 8.14% to $1.13. The market value of their outstanding shares is at $12.9 million.
- Shuttle Pharmaceuticals (NASDAQ:SHPH) stock declined by 7.81% to $3.78. The company's market cap stands at $5.0 million.
- I-MAB (NASDAQ:IMAB) stock fell 7.76% to $4.4. The company's market cap stands at $559.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Contact Us
Contact Number : +852 3852 8500Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2025 Webull Securities Limited. All rights reserved.